Synopsis
This meeting aims to showcase aspects of modern medicinal chemistry to bring new thinking to the subject, challenge perceptions and encourage scientific interaction between researchers. The short presentation format of the meeting also aims to provide a focussed forum to promote examples of medicinal chemistry excellence.
Attendees
This meeting is targeted at academic and industrial scientists engaged in all aspects of the drug discovery process and those interested in broadening their knowledge at the forefront of medicinal chemistry.
Programme
Thursday 8 October 2026
- 09.20
- Registration and refreshments
- 09.50
- Opening remarks
- 09.55
- Targeted protein degradation a decade on: From fundamental mechanisms to translational impact
Alessio Cuilli, University of Dundee
- 10.35
- A drug discovery journey in three dimensions
Anders Johanssen, AZ
- 11.15
- Refreshment break
- 11.45
- Tuning innate immune cell function to regulate inflammation and regeneration
David Cousin, Medchemica
- 12.25
- Talk 4 (abstract)
- 12.50
- Lunch
- 13.55
- Discovery of ASAP-0017445, A non-peptidic oral combined MERS-CoV and SARS-CoV-2 antiviral
Angela Russell, University of Oxford
- 14.35
- Talk 6 (abstract)
- 15.00
- Talk 7 (abstract)
- 15.25
- Refreshment break
- 15.55
- Title to be confirmed
Anna Barnard, Imperial College, London
- 16.35
- Approaches and considerations for the discovery of covalent inhibitors
Mike Waring, University of Newcastle
- 17.15
- Closing remarks
- 17.20
- Networking reception
SCI’s Fine Chemicals Group are committed to promoting diversity and equality in the chemical sciences. We aim to identify high quality speakers for all our conferences with full inclusivity where attendees from all backgrounds are welcome. We are open to offering flexible presentation options.
Sponsorship and exhibition information
Please see the sponsorship pack and email conferences@soci.org to let us know which package you are interested in.
Call for oral abstracts
Abstracts for focused 20-minute talks with contributions from the whole field of medicinal chemistry are now invited: please submit a one-page abstract to
conferences@soci.org
by
Friday 1 May 2026, with “Highlights VI – short talk abstract” in the subject line. An
Abstract_Template can be downloaded
Accessibility Grants
SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.
Venue and Contact
Fees
Before early bird - ends Thursday 10 September
SCI Member - £95
Non-member - £135
SCI Student member - £50
After early bird
SCI Member - £135
Non-member - £170
SCI Student member - £70
All registrations will automatically receive a confirmation within 24 hours of registering for the event. Should you not receive written confirmation of your booking, please email conferences@soci.org.
Become an SCI Member and save on this and future events
See Membership Options
Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
Booking Process/Deadlines
Booking terms and conditions
CPD Info
All delegates attending this meeting are able to claim CPD points.

Organising committee
Dr Nicola Chessum, Boehringer Ingelheim RCV GmbH & Co KG
Dr Helen Horsley, UCB
Dr Joanne Pinder, Vertex Pharmaceuticals (Europe) Ltd
Dr Hugh Tawell, Domainex